This page lists the SEC filings reported by Avoro Capital Advisors LLC.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | Mirati Therapeutics, Inc. | 5,075,000 | 9.2% | EDGAR |
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | MARINUS PHARMACEUTICALS INC | 3,235,000 | 8.8% | EDGAR |
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | Adverum Biotechnologies, Inc. | 6,950,000 | 7.1% | EDGAR |
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | UNITED THERAPEUTICS Corp | 3,035,000 | 6.7% | EDGAR |
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | CymaBay Therapeutics, Inc. | 12,800,000 | 14.7% | EDGAR |
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | MADRIGAL PHARMACEUTICALS, INC. | 1,425,000 | 8.3% | EDGAR |
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | IOVANCE BIOTHERAPEUTICS, INC. | 8,675,000 | 5.5% | EDGAR |
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | PMV Pharmaceuticals, Inc. | 1,465,000 | 3.2% | EDGAR |
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | ARENA PHARMACEUTICALS INC | 1,235,000 | 2.0% | EDGAR |
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | AVADEL PHARMACEUTICALS PLC | 1,670,000 | 2.9% | EDGAR |
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | FENNEC PHARMACEUTICALS INC. | 1,200,000 | 4.6% | EDGAR |
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | RELMADA THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | POINT Biopharma Global Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2022-02-11 | Avoro Capital Advisors LLC | Apellis Pharmaceuticals, Inc. | 8,555,555 | 8.9% | EDGAR |
| SC 13G | 2022-02-11 | Avoro Capital Advisors LLC | IO Biotech, Inc. | 2,055,883 | 7.1% | EDGAR |
| SC 13G | 2022-02-11 | Avoro Capital Advisors LLC | AMICUS THERAPEUTICS, INC. | 18,500,000 | 6.6% | EDGAR |
| SC 13G | 2022-02-11 | Avoro Capital Advisors LLC | Monte Rosa Therapeutics, Inc. | 3,311,434 | 7.1% | EDGAR |
| SC 13D/A | 2021-11-24 | Avoro Capital Advisors LLC | ACCELERON PHARMA INC | - | 0.0% | EDGAR |
| SC 13D | 2021-10-05 | Avoro Capital Advisors LLC | ACCELERON PHARMA INC | 4,476,100 | 7.3% | EDGAR |
| SC 13D/A | 2021-08-30 | Avoro Capital Advisors LLC | Aadi Bioscience, Inc. | 1,829,402 | 8.8% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.